• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低钠血症和血管加压素分泌的激活均与 30 天死亡率独立相关:一项多中心观察性研究的结果。

Hyponatremia and activation of vasopressin secretion are both independently associated with 30-day mortality: results of a multicenter, observational study.

机构信息

Division of General Internal and Emergency Medicine, University Department of Medicine, Kantonsspital Aarau, Aarau, Switzerland.

Emergency Department, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.

出版信息

J Intern Med. 2018 Sep;284(3):270-281. doi: 10.1111/joim.12764. Epub 2018 May 7.

DOI:10.1111/joim.12764
PMID:29664160
Abstract

BACKGROUND

Hyponatremia is a common feature of acute illness and associated with increased mortality. This may be explained by a stress-mediated activation of the vasopressin system with an increase in free-water reabsorption.

OBJECTIVES

To investigate whether the association between hyponatremia and mortality could be explained by activation of the vasopressin system.

METHODS

We prospectively enrolled adult, medical patients seeking emergency care in three centres in Switzerland, France and the United States. We investigated associations between admission plasma sodium and copeptin, a stable portion of the vasopressin-precursor peptide, with 30-day mortality. We performed uni- and multivariate regression analysis.

RESULTS

Of 6962 included patients, 18% had hyponatremia (sodium ≤135 mmol L ), which doubled their risk for mortality compared to patients with normonatremia (8.3% vs. 3.8%). This association was confirmed in a multivariate-adjusted logistic regression analysis [adjusted odds ratio (OR) 1.47, 95% CI 1.12-1.93, P = 0.005]. Vasopressin levels, mirrored by copeptin, were also increased in nonsurvivors and strongly associated with mortality (adjusted OR 3.42, 95% CI 2.76-4.25, P < 0.001). The association between hyponatremia and mortality remained unchanged when adding copeptin levels to the regression model (fully adjusted OR 1.53, 95% CI 1.16-2.00, P = 0.002).

CONCLUSION

This prospective study including medical patients upon emergency room admission found hyponatremia as well as an activation of the vasopressin system to be independently associated with mortality. This suggests that stress- and vasopressin-independent mechanisms are responsible for the association of low sodium levels with mortality.

摘要

背景

低钠血症是急性疾病的常见特征,与死亡率增加有关。这可能是由于应激介导的血管加压素系统激活,导致自由水重吸收增加所致。

目的

研究低钠血症与死亡率之间的关联是否可以用血管加压素系统的激活来解释。

方法

我们前瞻性纳入了在瑞士、法国和美国的三个中心寻求急诊治疗的成年内科患者。我们调查了入院时血浆钠和 copeptin(血管加压素前体肽的稳定部分)与 30 天死亡率之间的关系。我们进行了单变量和多变量回归分析。

结果

在纳入的 6962 例患者中,18%患有低钠血症(钠≤135mmol/L),与正常钠血症患者相比,其死亡率增加一倍(8.3% vs. 3.8%)。这一关联在多变量调整后的逻辑回归分析中得到了证实[调整后的优势比(OR)1.47,95%置信区间(CI)1.12-1.93,P=0.005]。反映血管加压素水平的 copeptin 在非幸存者中也升高,与死亡率密切相关(调整后的 OR 3.42,95%CI 2.76-4.25,P<0.001)。当将 copeptin 水平加入回归模型时,低钠血症与死亡率之间的关联仍然不变(完全调整后的 OR 1.53,95%CI 1.16-2.00,P=0.002)。

结论

这项包括急诊室入院内科患者的前瞻性研究发现,低钠血症和血管加压素系统的激活与死亡率独立相关。这表明,低钠血症与死亡率之间的关联与应激和血管加压素无关的机制有关。

相似文献

1
Hyponatremia and activation of vasopressin secretion are both independently associated with 30-day mortality: results of a multicenter, observational study.低钠血症和血管加压素分泌的激活均与 30 天死亡率独立相关:一项多中心观察性研究的结果。
J Intern Med. 2018 Sep;284(3):270-281. doi: 10.1111/joim.12764. Epub 2018 May 7.
2
Is the association of serum sodium with mortality in patients with type 2 diabetes explained by copeptin or NT-proBNP? (ZODIAC-46).2型糖尿病患者血清钠与死亡率之间的关联可由 copeptin 或 NT-proBNP 来解释吗?(ZODIAC-46)
Atherosclerosis. 2015 Sep;242(1):179-85. doi: 10.1016/j.atherosclerosis.2015.07.010. Epub 2015 Jul 8.
3
Changes in copeptin and bioactive vasopressin in runners with and without hyponatremia.伴有和不伴有低钠血症的跑步者中copeptin 和生物活性血管加压素的变化。
Clin J Sport Med. 2011 May;21(3):211-7. doi: 10.1097/JSM.0b013e31821a62c2.
4
Dysnatremia, vasopressin, atrial natriuretic peptide and mortality in patients with community-acquired pneumonia: results from the german competence network CAPNETZ.社区获得性肺炎患者的低钠血症、血管加压素、心房利钠肽与死亡率:德国CAPNETZ能力网络的研究结果
Respir Med. 2014 Nov;108(11):1696-705. doi: 10.1016/j.rmed.2014.09.014. Epub 2014 Oct 2.
5
The use of copeptin, the stable peptide of the vasopressin precursor, in the differential diagnosis of sodium imbalance in patients with acute diseases.在急性疾病患者钠失衡的鉴别诊断中,使用加压素前体的稳定肽 copeptin。
Swiss Med Wkly. 2011 Oct 11;141:w13270. doi: 10.4414/smw.2011.13270. eCollection 2011.
6
Association of hyponatremia and elevated copeptin with death and need for transplantation in ambulatory patients with chronic heart failure.低钠血症和copeptin 升高与慢性心力衰竭门诊患者的死亡和移植需求相关。
Am J Cardiol. 2013 Mar 15;111(6):880-5. doi: 10.1016/j.amjcard.2012.11.053. Epub 2012 Dec 28.
7
Plasma copeptin levels and prediction of outcome in heart failure outpatients: relation to hyponatremia and loop diuretic doses.血浆 copeptin 水平与心力衰竭门诊患者预后的关系:与低钠血症和袢利尿剂剂量的关系。
J Card Fail. 2012 May;18(5):351-8. doi: 10.1016/j.cardfail.2012.01.019. Epub 2012 Mar 10.
8
Copeptin as a biomarker and a diagnostic tool in the evaluation of patients with polyuria-polydipsia and hyponatremia.copeptin作为评估多尿-多饮和低钠血症患者的生物标志物和诊断工具。
Best Pract Res Clin Endocrinol Metab. 2016 Mar;30(2):235-47. doi: 10.1016/j.beem.2016.02.003. Epub 2016 Feb 16.
9
Trajectories of Serum Sodium on In-Hospital and 1-Year Survival among Hospitalized Patients.住院患者血清钠水平的变化轨迹与住院期间及 1 年生存的关系。
Clin J Am Soc Nephrol. 2020 May 7;15(5):600-607. doi: 10.2215/CJN.12281019. Epub 2020 Mar 25.
10
An abnormal apelin/vasopressin balance may contribute to water retention in patients with the syndrome of inappropriate antidiuretic hormone (SIADH) and heart failure.异常的apelin/血管加压素平衡可能导致抗利尿激素不适当分泌综合征(SIADH)和心力衰竭患者的水潴留。
J Clin Endocrinol Metab. 2013 May;98(5):2084-9. doi: 10.1210/jc.2012-3794. Epub 2013 Mar 20.

引用本文的文献

1
Thiazide-Associated Hyponatremia and Mortality Risk: A Cohort Study.噻嗪类药物相关低钠血症与死亡风险:一项队列研究
Kidney Med. 2024 Dec 9;7(2):100941. doi: 10.1016/j.xkme.2024.100941. eCollection 2025 Feb.
2
Impact of hyponatremia in patients hospitalized in Internal Medicine units: Hyponatremia in Internal Medicine units.内科住院患者低钠血症的影响:内科的低钠血症。
Medicine (Baltimore). 2024 May 24;103(21):e38312. doi: 10.1097/MD.0000000000038312.
3
Hyponatremia and Cancer: From Bedside to Benchside.低钠血症与癌症:从床边到实验室
Cancers (Basel). 2023 Feb 13;15(4):1197. doi: 10.3390/cancers15041197.
4
Nomogram Prediction Model of Hypernatremia on Mortality in Critically Ill Patients.危重症患者高钠血症对死亡率的列线图预测模型
Infect Drug Resist. 2023 Jan 6;16:143-153. doi: 10.2147/IDR.S387995. eCollection 2023.
5
Hyponatremia and Oxidative Stress.低钠血症与氧化应激
Antioxidants (Basel). 2021 Nov 4;10(11):1768. doi: 10.3390/antiox10111768.
6
Increased Mortality in Elderly Patients Admitted with Hyponatremia: A Prospective Cohort Study.低钠血症老年住院患者死亡率增加:一项前瞻性队列研究。
J Clin Med. 2021 Jul 10;10(14):3059. doi: 10.3390/jcm10143059.
7
Dysnatremia is a Predictor for Morbidity and Mortality in Hospitalized Patients with COVID-19.低钠血症是新冠病毒肺炎住院患者发病和死亡的一个预测指标。
J Clin Endocrinol Metab. 2021 May 13;106(6):1637-1648. doi: 10.1210/clinem/dgab107.
8
Risk of Adverse Clinical Outcomes in Hyponatremic Adult Patients Hospitalized for Acute Medical Conditions: A Population-Based Cohort Study.低钠血症成年患者住院治疗急性医学病症的不良临床结局风险:一项基于人群的队列研究。
J Clin Endocrinol Metab. 2020 Nov 1;105(11):3428-36. doi: 10.1210/clinem/dgaa547.
9
Sex-specific risks of death in patients hospitalized for hyponatremia: a population-based study.低钠血症住院患者的性别特异性死亡风险:一项基于人群的研究。
Endocrine. 2019 Dec;66(3):660-665. doi: 10.1007/s12020-019-02073-x. Epub 2019 Sep 2.